Cost analysis of neonatal and pediatric parenteral nutrition in Europe: a multi-country study

E Walter1, F X Liu, P Maton

  • 1Institute for Pharmacoeconomic Research, Vienna, Austria. e.walter@ipf-ac.at

Insights

The total costs of compounding parenteral nutrition (PN) vary by European country, with staff time being the largest expense. These findings are crucial for optimizing healthcare resource allocation in pediatric and neonatal care.

Area of Science:

  • Medical Economics
  • Pediatric Nutrition
  • Hospital Pharmacy

Background:

  • Parenteral nutrition (PN) is essential for neonates, infants, and children unable to receive enteral feeding.
  • Accurate cost assessment of PN compounding is vital for healthcare resource management.

Purpose of the Study:

  • To determine the total costs associated with compounding parenteral nutrition (PN) for pediatric and neonatal patients.
  • To analyze cost variations across different European countries.

Main Methods:

  • A bottom-up cost model was developed using data from 12 hospitals in Belgium, France, Germany, and the UK.
  • Resource utilization, including nutrients, staff time, equipment, and supplies, was collected via interviews.
  • Monetary values were assigned using published list prices and interview data.

Main Results:

  • The average daily cost per PN bag varied by age group and country, ranging from €55.16 for neonates to €118.02 for children (2-18 years).
  • Staff wages constituted the largest cost component, accounting for 54% of total costs for neonates and 28% for older children.
  • Nutrients represented 25% of costs for neonates and 63% for children, while supplies and equipment were minor contributors.

Conclusions:

  • Parenteral nutrition compounding costs demonstrate significant inter-country variability.
  • Staff time is a primary driver of overall PN therapy costs, highlighting areas for potential cost-efficiency improvements.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...